Cambridge Investment Research Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $196K | Buy |
|
|||||
|
2025
Q2 | $139K | Buy |
|
|||||
|
2025
Q1 | $134K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $149K | Buy |
|
|||||
|
2023
Q4 | $140K | Sell |
|
|||||
|
2023
Q3 | $143K | Sell |
|
|||||
|
2023
Q2 | $166K | Buy |
|
|||||
|
2023
Q1 | $168K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $217K | Buy |
|
|||||
|
2022
Q1 | $247K | Buy |
|
|||||
|
2021
Q4 | $249K | Buy |
|
|||||
|
2021
Q3 | $254K | Buy |
|
|||||
|
2021
Q2 | $253K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $748K | Sell |
|
|||||
|
2019
Q2 | $878K | Buy |
|
|||||
|
2019
Q1 | $844K | Buy |
|
|||||
|
2018
Q4 | $664K | Sell |
|
|||||
|
2018
Q3 | $1.08M | Buy |
|
|||||
|
2018
Q2 | $969K | Sell |
|
|||||
|
2018
Q1 | $1M | Buy |
|
|||||
|
2017
Q4 | $1.01M | Buy |
|
|||||
|
2017
Q3 | $923K | Buy |
|
|||||
|
2017
Q2 | $862K | Sell |
|
|||||
|
2017
Q1 | $903K | Buy |
|
|||||
|
2016
Q4 | $790K | Buy |
|
|||||
|
2016
Q3 | $841K | Sell |
|
|||||
|
2016
Q2 | $788K | Buy |
|
|||||
|
2016
Q1 | $672K | Buy |
|
|||||
|
2015
Q4 | $743K | Buy |
|
|||||
|
2015
Q3 | $671K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $206K | Buy |
|